A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells
Yinxing Shen,1,2 Mengya Li,1 Tianqi Liu,1 Jing Liu,2 Youhua Xie,2 Junqi Zhang,2 Shouhong Xu,1 Honglai Liu11Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, People’s Republic of China; 2Ke...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/a5feb160141744239f3cd45c0e94bdf0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:a5feb160141744239f3cd45c0e94bdf0 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:a5feb160141744239f3cd45c0e94bdf02021-12-02T08:15:52ZA dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells1178-2013https://doaj.org/article/a5feb160141744239f3cd45c0e94bdf02019-05-01T00:00:00Zhttps://www.dovepress.com/a-dual-functional-her2-aptamer-conjugated-ph-activated-mesoporous-sili-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yinxing Shen,1,2 Mengya Li,1 Tianqi Liu,1 Jing Liu,2 Youhua Xie,2 Junqi Zhang,2 Shouhong Xu,1 Honglai Liu11Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, People’s Republic of China; 2Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of ChinaPurpose: As well as functioning as a ligand that is selectively internalized by cells overexpressing human epidermal growth factor receptor-2 (HER2), HApt can exert cytotoxic effects by inducing cross-linking and subsequent translocation of HER2 to cytoplasmic vesicles, such downregulation of HER2 inhibits cell proliferation and induces apoptosis. We aimed to exploit the potential of HApt as both a targeting agent and antagonist to maximize the efficacy of mesoporous silica nanoparticle (MSN)-based drug release systems for HER2-positive breast cancer.Materials and methods: We fabricated novel HApt aptamer-functionalized pH-sensitive β-cyclodextrin (β-CD)-capped doxorubicin (DOX)-loaded mesoporous silica nanoparticles (termed MSN-BM/CD-HApt@DOX) for targeted delivery and selective targeting of HER2-positive cells. MSN-functionalized benzimidazole (MSN-BM) was used to load and achieve pH stimuli-responsive release of the chemotherapeutic agent doxorubicin (DOX). β-cyclodextrin was introduced as a gatekeeper for encapsulated DOX and HApt as a selective HER2-targeting moiety and biotherapeutic agent.Results: Physical and chemical characterizations (FT-IR, XRD, TEM and BET) confirmed successful construction of MSN-BM/CD-HApt@DOX nanoparticles. In vitro release assays verified pH-sensitive DOX release. MSN-BM/CD-HApt@DOX (relative DOX concentration, 3.6 μg/mL) underwent HER2-mediated endocytosis and was more cytotoxic to HER2-positive SKBR3 cells than HER2-negative MCF7 cells. MSN-BM/CD-HApt@DOX also exhibited better uptake and stronger growth inhibition in SKBR3 cells than the control MSN-BM/CD-NCApt@DOX functionalized with a scrambled nucleotide sequence on CD. Overall, intracellular delivery of DOX and the biotherapeutic agent HApt resulted in synergistic cytotoxic effects in HER2-positive cancer cells in comparison to either DOX or HApt alone.Conclusion: MSN-BM/CD-HApt@DOX enables HER2-mediated targeting and biotherapeutic effects as well as pH-responsive DOX drug release, resulting in synergistic cytotoxic effects in HER2-overexpressing cells in vitro. This novel nanocarrier could potentially enable specific targeting to improve the efficacy of chemotherapy for HER2-positive cancer.Keywords: mesoporous silica nanoparticle, pH-sensitive nanovalve, HER2 aptamer, synergistic cytotoxicityShen YLi MLiu TLiu JXie YZhang JXu SLiu HDove Medical Pressarticlemesoporous silica nanoparticlepH-sensitive nanovalveHER2 aptamersynergistic cytotoxicityMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 4029-4044 (2019) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
mesoporous silica nanoparticle pH-sensitive nanovalve HER2 aptamer synergistic cytotoxicity Medicine (General) R5-920 |
| spellingShingle |
mesoporous silica nanoparticle pH-sensitive nanovalve HER2 aptamer synergistic cytotoxicity Medicine (General) R5-920 Shen Y Li M Liu T Liu J Xie Y Zhang J Xu S Liu H A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells |
| description |
Yinxing Shen,1,2 Mengya Li,1 Tianqi Liu,1 Jing Liu,2 Youhua Xie,2 Junqi Zhang,2 Shouhong Xu,1 Honglai Liu11Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, People’s Republic of China; 2Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of ChinaPurpose: As well as functioning as a ligand that is selectively internalized by cells overexpressing human epidermal growth factor receptor-2 (HER2), HApt can exert cytotoxic effects by inducing cross-linking and subsequent translocation of HER2 to cytoplasmic vesicles, such downregulation of HER2 inhibits cell proliferation and induces apoptosis. We aimed to exploit the potential of HApt as both a targeting agent and antagonist to maximize the efficacy of mesoporous silica nanoparticle (MSN)-based drug release systems for HER2-positive breast cancer.Materials and methods: We fabricated novel HApt aptamer-functionalized pH-sensitive β-cyclodextrin (β-CD)-capped doxorubicin (DOX)-loaded mesoporous silica nanoparticles (termed MSN-BM/CD-HApt@DOX) for targeted delivery and selective targeting of HER2-positive cells. MSN-functionalized benzimidazole (MSN-BM) was used to load and achieve pH stimuli-responsive release of the chemotherapeutic agent doxorubicin (DOX). β-cyclodextrin was introduced as a gatekeeper for encapsulated DOX and HApt as a selective HER2-targeting moiety and biotherapeutic agent.Results: Physical and chemical characterizations (FT-IR, XRD, TEM and BET) confirmed successful construction of MSN-BM/CD-HApt@DOX nanoparticles. In vitro release assays verified pH-sensitive DOX release. MSN-BM/CD-HApt@DOX (relative DOX concentration, 3.6 μg/mL) underwent HER2-mediated endocytosis and was more cytotoxic to HER2-positive SKBR3 cells than HER2-negative MCF7 cells. MSN-BM/CD-HApt@DOX also exhibited better uptake and stronger growth inhibition in SKBR3 cells than the control MSN-BM/CD-NCApt@DOX functionalized with a scrambled nucleotide sequence on CD. Overall, intracellular delivery of DOX and the biotherapeutic agent HApt resulted in synergistic cytotoxic effects in HER2-positive cancer cells in comparison to either DOX or HApt alone.Conclusion: MSN-BM/CD-HApt@DOX enables HER2-mediated targeting and biotherapeutic effects as well as pH-responsive DOX drug release, resulting in synergistic cytotoxic effects in HER2-overexpressing cells in vitro. This novel nanocarrier could potentially enable specific targeting to improve the efficacy of chemotherapy for HER2-positive cancer.Keywords: mesoporous silica nanoparticle, pH-sensitive nanovalve, HER2 aptamer, synergistic cytotoxicity |
| format |
article |
| author |
Shen Y Li M Liu T Liu J Xie Y Zhang J Xu S Liu H |
| author_facet |
Shen Y Li M Liu T Liu J Xie Y Zhang J Xu S Liu H |
| author_sort |
Shen Y |
| title |
A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells |
| title_short |
A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells |
| title_full |
A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells |
| title_fullStr |
A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells |
| title_full_unstemmed |
A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells |
| title_sort |
dual-functional her2 aptamer-conjugated, ph-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in her2-positive breast cancer cells |
| publisher |
Dove Medical Press |
| publishDate |
2019 |
| url |
https://doaj.org/article/a5feb160141744239f3cd45c0e94bdf0 |
| work_keys_str_mv |
AT sheny adualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT lim adualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT liut adualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT liuj adualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT xiey adualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT zhangj adualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT xus adualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT liuh adualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT sheny dualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT lim dualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT liut dualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT liuj dualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT xiey dualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT zhangj dualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT xus dualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells AT liuh dualfunctionalher2aptamerconjugatedphactivatedmesoporoussilicananocarrierbaseddrugdeliverysystemprovidesinvitrosynergisticcytotoxicityinher2positivebreastcancercells |
| _version_ |
1718398619501985792 |